Neuroscience, Science, Research, Brain.
not involved in the study. However, the large treatment effect also came with a high number of adverse events. The most frequent were dizziness and double vision — occurring in 44% of the esketamine group and 22% of the placebo group — though these lasted less than a day and did not require drug